Financials
| Posting of Annual Report and Revised Notice of AGM | Jun. 09, 2025 |
| Interim Results | Sep. 30, 2024 |
| Full Year Results | Apr. 30, 2024 |
| Interim Results for the Period Ending 30 June 2023 | Sep. 28, 2023 |
| Preliminary Results | Apr. 25, 2023 |
| Interim Results for the Period Ended 30 June 2022 | Sep. 29, 2022 |
| Preliminary Results | Apr. 06, 2022 |
Proxies
| Result of AGM | Jul. 02, 2025 |
| Result of AGM | Jun. 26, 2024 |
| Posting of Annual Report and Notice of AGM | May. 31, 2024 |
| Result of General Meeting | Mar. 18, 2024 |
| Result of Annual General Meeting | Jun. 28, 2023 |
| Posting of Annual Report and Notice of AGM | Jun. 02, 2023 |
| Result of Annual General Meeting | Jun. 23, 2022 |
Ownership Update
| Director/PDMR Shareholdings and TVR | Sep. 02, 2024 |
| Director/PDMR Shareholding | Sep. 29, 2023 |
| Director/PDMR Shareholding | Nov. 08, 2022 |
| Director/PDMR Shareholding | Oct. 20, 2022 |
| Holding(s) in Company | Jun. 09, 2021 |
| Director/PDMR Shareholding | Oct. 22, 2020 |
| Holding(s) in Company | Aug. 11, 2020 |
Announcements
| Avacta to Present at ESMO Congress | Jul. 30, 2025 |
| Agreement to Sell Coris Bioconcept SRL | Jul. 28, 2025 |
| Payment of Convertible Bond Installment | Jul. 21, 2025 |
| Q2 2025 Business Update | Jul. 02, 2025 |
| Appointment of Zeus Capital as Joint Broker | Jun. 30, 2025 |
| New Response in Phase 1b Trial | Jun. 19, 2025 |
| Avacta Change in Prelim Date Part 2 | Jun. 04, 2025 |